TenNor Therapeutics Reports Stable Share Base and Confirms Public Float Compliance for June 2026

Bulletin Express14:09

TenNor Therapeutics (Suzhou) Limited released its Monthly Return for Equity Issuer for the period ended 30 June 2026, indicating no changes in share capital structure during the month.

The company’s issued H-share capital remained at 52.33 million ordinary shares with a par value of RMB 1 each, identical to the prior month. No shares were issued, repurchased, cancelled or held in treasury, leaving total issued shares unchanged at 52.33 million.

TenNor Therapeutics confirmed that it satisfied the Hong Kong Stock Exchange’s minimum 25% public-float requirement as of 30 June 2026. The filing also shows that the company has no outstanding share option schemes, warrants, convertible securities or other agreements that could dilute its share base.

The return was signed by Chairman and Chief Executive Officer Ma Zhenkun on 3 July 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1121790734?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-03 14:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1121790734","market":"us","top_or_hot":-1,"title":"TenNor Therapeutics Reports Stable Share Base and Confirms Public Float Compliance for June 2026","media":"Bulletin Express","content":"<p>TenNor Therapeutics (Suzhou) Limited released its Monthly Return for Equity Issuer for the period ended 30 June 2026, indicating no changes in share capital structure during the month.</p>\n<p>The company’s issued H-share capital remained at 52.33 million ordinary shares with a par value of RMB 1 each, identical to the prior month. No shares were issued, repurchased, cancelled or held in treasury, leaving total issued shares unchanged at 52.33 million.</p>\n<p>TenNor Therapeutics confirmed that it satisfied the Hong Kong Stock Exchange’s minimum 25% public-float requirement as of 30 June 2026. The filing also shows that the company has no outstanding share option schemes, warrants, convertible securities or other agreements that could dilute its share base.</p>\n<p>The return was signed by Chairman and Chief Executive Officer Ma Zhenkun on 3 July 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TenNor Therapeutics Reports Stable Share Base and Confirms Public Float Compliance for June 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTenNor Therapeutics Reports Stable Share Base and Confirms Public Float Compliance for June 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-03 14:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>TenNor Therapeutics (Suzhou) Limited released its Monthly Return for Equity Issuer for the period ended 30 June 2026, indicating no changes in share capital structure during the month.</p>\n<p>The company’s issued H-share capital remained at 52.33 million ordinary shares with a par value of RMB 1 each, identical to the prior month. No shares were issued, repurchased, cancelled or held in treasury, leaving total issued shares unchanged at 52.33 million.</p>\n<p>TenNor Therapeutics confirmed that it satisfied the Hong Kong Stock Exchange’s minimum 25% public-float requirement as of 30 June 2026. The filing also shows that the company has no outstanding share option schemes, warrants, convertible securities or other agreements that could dilute its share base.</p>\n<p>The return was signed by Chairman and Chief Executive Officer Ma Zhenkun on 3 July 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06872","symbol_name":"丹诺医药-B","start_time":0,"source_url":"","article_id":"1121790734","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1121790734","pubTimestamp":1783058961,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"TenNor Therapeutics (Suzhou) Limited released its Monthly Return for Equity Issuer for the period ended 30 June 2026, indicating no changes in share capital structure during the month. The company’s...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06872":"丹诺医药-B"},"translate_title":"TenNor Therapeutics报告稳定的股票基础并确认2026年6月的公众持股量合规性","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06872":1},"content_text":"TenNor Therapeutics (Suzhou) Limited released its Monthly Return for Equity Issuer for the period ended 30 June 2026, indicating no changes in share capital structure during the month.\nThe company’s issued H-share capital remained at 52.33 million ordinary shares with a par value of RMB 1 each, identical to the prior month. No shares were issued, repurchased, cancelled or held in treasury, leaving total issued shares unchanged at 52.33 million.\nTenNor Therapeutics confirmed that it satisfied the Hong Kong Stock Exchange’s minimum 25% public-float requirement as of 30 June 2026. The filing also shows that the company has no outstanding share option schemes, warrants, convertible securities or other agreements that could dilute its share base.\nThe return was signed by Chairman and Chief Executive Officer Ma Zhenkun on 3 July 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1121790734","isCrawlerRequest":true}